P3.16-09 High Preoperative D-Dimer Level Predicts Early Recurrence After Surgery for Non-Small Cell Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1916
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P3.16-44 Robotic-Assisted Thoracic Surgery for Early-Stage Non-Small-Cell Lung Cancer: Initial Experience in Brazil

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Salvage Surgery for Local Recurrence After Stereotactic Body Radiotherapy for Early Stage Non-Small Cell Lung Cancer: A Systematic Review

Therapeutic Advances in Medical Oncology
Oncology
2018English

P3.08-09 Surgical Resection of Pulmonary Oligo-Recurrence of Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.16-041 Pleural Photodynamic Therapy and Surgery for Pleural Metastasis by Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Local Recurrence After Surgery for Non–small Cell Lung Cancer: A Recursive Partitioning Analysis of Multi-Institutional Data

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2013English

P3.16-33 Characteristics and Risk Factors of Recurrence After Segmentectomy in Patients With Clinical Stage I Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

MA01.11 Salvage SBRT for Local Recurrence After Primary Surgical Resection of Early Stage Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Prognostic Significance of Preoperative Plasma D-Dimer Level in Patients With Surgically Resected Clinical Stage I Non-Small Cell Lung Cancer: A Retrospective Cohort Study

Journal of Cardiothoracic Surgery
CardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2017English

CPSF3 Is a Promising Prognostic Biomarker and Predicts Recurrence of Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy